Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

restless legs syndrome

- PMLiVE

FDA approves second over-the-counter naloxone nasal spray for opioid overdose

Over 105,000 fatal opioid overdoses were reported in the US between 2022 and 2023

- PMLiVE

EMA accepts Mundipharma’s application for invasive candidiasis treatment rezafungin

Despite currently available treatments, the mortality rate for patients with invasive candidiasis remains high at up to 40%

- PMLiVE

THE HIDDEN LIFESAVERS: overdose prevention campaign launches nationwide

The campaign encourages people who use drugs to do something remarkable – save a life

Havas Lynx

- PMLiVE

Mundipharma adds breast cancer biosimilar to its portfolio with Celltrion deal

Will launch Herzuma in seven European countries including the UK and Germany

- PMLiVE

Mundipharma appoints Dr Alberto Martinez as president and CEO

He succeeds Antony Mattessich, who leaves after 12 years with the networked company

- PMLiVE

Mundipharma appoints chief information officer

Philippe Mazas joins the UK-based pharma network from Smith & Nephew

- PMLiVE

When science is not enough

Mundipharma’s Will Dunlop on a new framework to guide development programmes to a better destination

- PMLiVE

Mundipharma to launch first MabThera biosimilar in EU

EMA approves Truxima in all indications licensed to Roche’s cancer drug

- PMLiVE

Study finds no problems switching from Remicade to biosimilar

Findings look to dispel ‘biosimilar resistance’ and encourage greater uptake

- PMLiVE

Remicade biosimilars hit European market

Hospira and Mundipharma begin marketing their version of the blockbuster drug

- PMLiVE

EC gives nod to restless leg syndrome drug Targin

Mundipharma’s medicine is first opioid granted a licence for condition in the EU

- PMLiVE

Successful partnerships in pharma: Skyepharma and Mundipharma

Why skills and flexibility matter more than sheer size

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links